LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

LLY

764.43

-0.25%↓

JNJ

153.41

0%↓

ABBV

187.23

-0.07%↓

NVO

72.52

+0.35%↑

UNH

295.54

-1.64%↓

Search

Fulgent Genetics Inc

Geschlossen

BrancheGesundheitswesen

20.73 -2.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

20.66

Max

21.31

Schlüsselkennzahlen

By Trading Economics

Einkommen

-5.7M

-12M

Verkäufe

-2.8M

73M

EPS

0.04

Gewinnspanne

-16.197

Angestellte

1,313

EBITDA

-2M

-12M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+12.73% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

1. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

57M

629M

Vorheriger Eröffnungskurs

23.09

Vorheriger Schlusskurs

20.73

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Fulgent Genetics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Juni 2025, 20:45 UTC

Ergebnisse

Broadcom 2Q Sales Climb on Booming AI Demand

5. Juni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. Juni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. Juni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. Juni 2025, 21:32 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. Juni 2025, 20:45 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:24 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Rev $15B >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Net $4.97B >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Adj EPS $1.58 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q EPS $1.03 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom Sees 3Q Rev $15.8B >AVGO

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. Juni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. Juni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. Juni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. Juni 2025, 18:26 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. Juni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. Juni 2025, 16:30 UTC

Akquisitionen, Fusionen, Übernahmen

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. Juni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. Juni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. Juni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. Juni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. Juni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. Juni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. Juni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Fulgent Genetics Inc Prognose

Kursziel

By TipRanks

12.73% Vorteil

12-Monats-Prognose

Durchschnitt 24 USD  12.73%

Hoch 25 USD

Tief 23 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fulgent Genetics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

1

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

17.32 / 19.04Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Neutral Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.